New Lung Cancer Pill Gets FDA Green Light

Big news for lung cancer treatment! The FDA just approved Nuvation Bio’s new once-a-day pill, Ibtrozi, for people with ROS1-positive non-small cell lung cancer. This is a rare type, but the new drug could be a game-changer for those who need more options. Love seeing progress like this in cancer care! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth